The management of Stallion India Fluorochemicals Limited will conduct an Analyst/Investor Meeting on Tuesday, 8th September 2026.
The meeting will be conducted virtually at the Registered Office of the Company.
The scheduled participant is Canara HSBC Life Insurance.
The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during this meeting.
Additional Notes Section
The disclosure includes a note that the schedule is subject to change due to exigencies on the part of the Company or the concerned analysts/investors, with any changes to be intimated to the Stock Exchanges where required.
No financial data, performance figures, or strategic updates were disclosed in this announcement.
The document was signed by Govind Rao, Company Secretary & Compliance Officer (Membership No.: ACS 47094) on 4th September 2026.